Search

A study conducted by researchers from the University of Kentucky College of Medicine evaluated the safety and efficacy of optic nerve sheath fenestration using visual acuity, perimetry, and optical coherence tomography. The study involved 55 patients who underwent the procedure, showing improvements in visual acuity, perimetric mean deviation, and optic disc edema after a 12-month follow-up. The research concluded that optic nerve sheath fenestration via a medial transconjunctival approach is a safe and effective method for preserving vision in patients with papilledema, especially in cases of idiopathic intracranial hypertension. [Extracted from the article]

2022 APR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Central Nervous System Diseases and Conditions - Pseudotumor [...]

Optic nerve sheath fenestration (ONSF) is a surgical technique commonly and effectively employed in the treatment of recalcitrant, vision-threatening papilledema. Unilateral blindness, a known risk of unilateral ONSF widely cited with 1%–2% incidence. In this case, a 58-year-old patient who presented symptomatic with bilateral hemorrhagic papilledema unresponsive to medical therapy underwent uneventful unilateral ONSF via standard superomedial eyelid crease incision. The patient presented postoperatively with severe bilateral vision loss. Workup revealed widespread metastatic malignant disease involving the optic chiasm and optic nerve sheath.The authors present an unusual case of widespread metastatic leptomeningeal carcinomatosis discovered after acute bilateral vision loss following unilateral optic nerve sheath fenestration.

According to the news reporters, the research concluded: "Early optic nerve sheath fenestration is an effective modality for treating optic disc edema due to a wide myriad of causes and helps resolve the associated symptoms." Keywords: Edema; Health and Medicine EN Edema Health and Medicine 269 269 1 07/24/23 20230730 NES 230730 2023 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on edema have been presented. Records of 18 eyes of 15 patients who underwent optic nerve sheath fenestration for vision threatening optic disc edema were reviewed retrospectively, and results were analyzed.". [Extracted from the article]

A study conducted at the Institute of Ophthalmology Mayo Hospital in Lahore, Pakistan, examined the efficacy and safety of Optic Nerve Sheath Fenestration (ONSF) in patients with Idiopathic Intracranial Hypertension (IIH). The study included nine female patients with a mean age of 24 years. After ONSF, there was a significant improvement in visual acuity in both eyes at various follow-up intervals. Some patients experienced minor complications, but overall, ONSF was found to be an effective and safe surgical procedure for salvaging vision in patients with IIH. [Extracted from the article]

Purpose: Optic nerve sheath fenestration (ONSF) is a surgical procedure commonly performed in the Anglo-Saxon countries for the treatment of medically refractory idiopathic intracranial hypertension (IIH). We chose to compare 6 different trans-orbital surgical approaches to ONSF. We also desired to determine the number of optic nerve decompression procedures performed in France in 2019 and 2020.

Brain Diseases and Conditions, Cardiovascular Diseases and Conditions, Central Nervous System Diseases and Conditions, Health and Medicine, Hypertension, Intracranial Hypertension, Pseudotumor Cerebri, Retinoic Acid, Therapy Keywords: Brain Diseases and Conditions; Cardiovascular Diseases and Conditions; Central Nervous System Diseases and Conditions; Health and Medicine; Hypertension; Intracranial Hypertension; Pseudotumor Cerebri; Retinoic Acid; Therapy EN Brain Diseases and Conditions Cardiovascular Diseases and Conditions Central Nervous System Diseases and Conditions Health and Medicine Hypertension Intracranial Hypertension Pseudotumor Cerebri Retinoic Acid Therapy 595 595 1 07/31/23 20230731 NES 230731 2023 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Fresh data on pseudotumor cerebri are presented in a new report. [Extracted from the article]

A systematic review conducted by University Hospital Padua in Italy focused on surgical and interventional radiology procedures for pediatric idiopathic intracranial hypertension (IIH). The study included 454 children or adolescents aged 11 months to 17 years, with 193 undergoing invasive approaches such as CSF diversion, optic nerve sheath fenestration (ONSF), and venous sinus stenting (VSS). Results showed that while CSF diversion is commonly used despite high failure rates, ONSF and VSS have shown positive outcomes, particularly in cases with visual symptoms. VSS demonstrated good results in symptom resolution and reintervention rates, although its use remains limited to a few centers. [Extracted from the article]

Welcome to a new era in “Lit Commentary!” I want to thank Tariq Bhatti for the past years of partnering with me in this endeavor. It has been a pleasure to collaborate with him. We now welcome 2 new colleagues to Lit Commentary, Deborah I. Friedman and Marc J. Dinkin, who will work along with me. This is our first “Rodeo” together and you can see we all have different approaches to our reviews. We look forward to finding our groove and get in to some appropriate banter as we ride along!—Mark L. Moster, MDIn this issue of JNO Drs. Marc J. Dinkin, Deborah I. Friedman and Mark L. Moster discuss the following 6 articles:Tu TM, Yi SJ, Koh JS, Saffari SE, Hoe RHM, Chen GJ, Chiew HJ, Tham CH, Seet CYH, Yong MH, Yong KP, Hui AC, Fan BE, Tan BY, Quek AML, Seet RCS, Yeo LLL, Tan K, Thirugnanam UN. Incidence of cerebral venous thrombosis following SARS-CoV-2 infection vs mRNA SARS-CoV-2 vaccination in Singapore. JAMA Netw Open. 2022;5:e222940.Douglas RS, Dailey R, Subramanian PS, Barbesino G, Ugradar S, Batten R, Qadeer RA, Cameron C. Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate-to-severe thyroid eye disease: a meta-analysis and matching-adjusted indirect comparison. JAMA Ophthalmol. 2022;140:328–335.Mikolajczyk B, Ritter A, Larson C, Connett J, Olson J, McClelland C, Lee MS. Red desaturation prevalence and severity in healthy patients. Neurol Clin Pract. 2022;12:1–5.Landau Prat D, Liu GT, Avery RA, Ying GS, Chen Y, Tomlinson LA, Revere KE, Katowitz JA, Katowitz WR. Recovery of vision after optic nerve sheath fenestration in children and adolescents with elevated intracranial pressure. Am J Ophthalmol. 2021;237:173–182.Hummert MW, Schoppe LM, Bellmann-Strobl J, Siebert N, Paul F, Duchow A, Pellkofer H, Kümpfel T, Havla J, Jarius S, Wildemann B, Berthele A, Bergh FT, Pawlitzki M, Klotz L, Kleiter I, Stangel M, Gingele S, Weber MS, Faiss JH, Pul R, Walter A, Zettl UK, Senel M, Stellmann J-P, Häußler V, Hellwig K, Ayzenberg I, Aktas O, Ringelstein M, Schreiber-Katz O, Trebst C; on behalf of the Neuromyelitis Optica Study Group (NEMOS). Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCENMO study. Neurology. 2022;98:e1184–e1196.Pineles SL, Henderson RJ, Repka MX, Heidary G, Liu GT, Waldman AT, Borchert MS, Khanna S, Graves JS, Collinge JE, Conley JA, Davis PL, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. The pediatric optic neuritis prospective outcomes study—two-year results. Ophthalmology. 2022:S0161-6420(22)00234-2. doi: 10.1016/j.ophtha.2022.03.021. Epub ahead of print. PMID: 35364222.

Objective To test the applicability of a fresh tissue model for teaching facial plastic techniques and approaches to the eyelids and orbit.Design Observational animal experiments.Subjects Ten prepubescent sheep heads harvested following humane euthanasia at the completion of unrelated live animal research.Methods Young sheep were saline perfused at the end of an in vivo protocol. Head and neck tissues were harvested and refrigerated for 3–7 days. An experienced oculoplastic surgeon and an otolaryngologist explored the feasibility of common oculoplastic procedures in the ovine model.Results The model has potential for teaching basic principles in eyelid surgery including upper lid blepharoplasty, aponeurotic ptosis repair, upper lid gold weight lid loading for facial paralysis, lateral canthotomy and inferior limb cantholysis, lower lid tightening, and transconjunctival approach to the orbital floor. Eye muscle advancement, optic nerve sheath fenestration, and enucleation also accurately simulated human surgery. Anatomic variations limit the sheep model for orbital floor reconstruction and lacrimal drainage procedures.Conclusions The sheep head and neck provide an inexpensive, safe model for developing skills in several oculoplastic procedures. Formal simulation testing is needed to confirm these expert opinions.

On the postoperative day 6, profound bilateral vision loss with counting fingers vision in OD and no light perception in OS was noted. The woman underwent optic nerve sheath fenestration of OS for bilateral haemorrhagic papilloedema. Acute Bilateral Vision Loss Following Unilateral Optic Nerve Sheath Fenestration. [Extracted from the article]

A 32-year-old woman developed pseudotumor cerebri syndrome (PTCS) while being treated with tretinoin for acute promyelocytic leukemia (APL). She experienced double vision, visual loss, and headaches two weeks after starting tretinoin. Examination revealed swollen optic discs, abducens paresis, and increased pressure at the optic nerve sheath. The woman was treated with acetazolamide, had her tretinoin dosage reduced, and underwent optic nerve sheath fenestration surgery. After six months, her vision and visual fields returned to normal. [Extracted from the article]

A 32-year-old woman with idiopathic intracranial hypertension (IIH) exhibited a lack of efficacy during treatment with acetazolamide and furosemide. Despite receiving these medications, her symptoms, including headache, joint pain, hearing loss, and tinnitus, did not improve. The woman had a history of cardiomyopathy, obesity, optic nerve atrophy, sensorineural hearing loss, polycystic ovarian syndrome (PCOS), and empty sella (ES) syndrome. She underwent optic nerve sheath fenestration but still developed bilateral blindness. Topiramate and promethazine were also administered, but her headache only improved temporarily. The woman continued treatment with promethazine, acetazolamide, and follow-up for over 6 months. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 59-year-old woman exhibited lack of efficacy during treatment with acetazolamide and unspecified corticosteroids for pseudotumor cerebri. Hence, optic nerve sheath fenestration was advised. The neurosurgery team deemed her as not a suitable candidate for a CSF shunting procedure, and the ophthalmologist advised against an optic nerve sheath fenestration. [Extracted from the article]

In their multicenter randomized controlled clinical trial of patients with idiopathic intracranial hypertension (IIH), Mollan et al. sought to determine the amount of weight loss necessary to achieve physiologic remission (intracranial pressure [ICP] ≤25 cm CSF). The investigators not only found that greater weight loss was achieved with bariatric surgery over community weight management but patients who underwent surgery experienced greater and more rapid reduction in ICP. Furthermore, only patients in the surgical arm achieved a fall in ICP to ≤25 cm, which was associated with a mean weight loss of approximately 24% from their baseline weight. Dr. Ramsamy and colleagues highlight that surgery was not associated with statistically significant improvement in visual outcomes or headache, which are the most disabling symptoms of IIH. In response, Dr. Mollan and their coinvestigators note the study was powered to demonstrate a treatment effect for the primary outcome of ICP reduction (as a biomarker of disease remission), rather than for secondary outcomes regarding visual or other symptoms of IIH. That said, the investigators admit there remains no consensus definition for clinical remission in IIH. Dr. Brenner also comments on the potential adjuvant use of caffeine in weight loss for patients with IIH and the benefits of optic nerve sheath fenestration when vision loss occurs. The investigators cite their original manuscript (published in JAMA Neurology), which reported a rapid and significant fall in ICP within 2 weeks of bariatric surgery. It is possible that acute hormonal changes after surgery such as a rapid rise in gut neuropeptide glucagon-like peptide-1 may have played a larger role in ICP reduction than weight loss alone.

A patent application for the treatment of intracranial stenosis has been filed by inventors from various locations in California. The application focuses on addressing idiopathic intracranial hypertension (IIH) and other conditions causing increased intracranial pressure. The proposed method involves deploying a stent in the venous sinuses to alleviate symptoms and improve blood flow, with the goal of preserving vision and managing headaches. The technology aims to provide a targeted treatment system for intracranial venous stenosis, offering potential benefits for patients suffering from IIH and related conditions. [Extracted from the article]

A patent application has been submitted for approval by inventors Michael Belkin, Yishay Falick, Nir Sinai, and Doron Smulian. The application describes a device and method for treating ocular diseases and degenerations in the posterior portion of the eye. The device includes a platform that can be attached to the eyeball and has a curved hollow conduit for injecting medical materials into precise locations in the eye. The platform aims to reduce the likelihood of complications and provide a more precise modality for treating diseases in the posterior parts of the eye. [Extracted from the article]

Idiopathic intracranial hypertension (IIH) is a triad of headaches, visual changes, and papilledema in the absence of a secondary cause for elevated intracranial pressure. There is an association with obesity, and the incidence is rising in parallel with the obesity epidemic. Sometimes these patients present initially to an otolaryngologist with complaints such as tinnitus, dizziness, hearing loss, and otorrhea or rhinorrhea from cerebrospinal fluid (CSF) leak. IIH diagnosis in conjunction with neurology and ophthalmology including neuroimaging and lumbar puncture with opening pressure is key to the management of this condition. Medical treatment with weight loss, diuretics, and other medications as well as surgical treatment of CSF leak, CSF diversion, transverse sinus stenting, and optic nerve sheath fenestration are discussed. It is important for otolaryngologists to recognize IIH as a possible diagnosis in patients and initiate appropriate referrals and treatment.

This document provides information about a clinical trial, NCT06436820, that aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow in patients with idiopathic intracranial hypertension (IIH). The study will observe changes in aqueous outflow facility in patients scheduled for lumbar puncture (LP) to investigate the effect of lumbar puncture-induced reduction in ICP on patients with IIH compared to control patients. The study also aims to compare pre-lumbar puncture aqueous outflow facility between patients with IIH and control patients. The goal is to understand the relationship between ICP and aqueous outflow and potentially provide a non-invasive measurement for intracranial pressure. The trial is not yet recruiting participants, and the estimated completion date is November 2025. The eligibility criteria for participants are outlined, and the responsible party for the trial is Guy's and St Thomas' NHS Foundation Trust. [Extracted from the article]

A report from Hospital Clinic in Barcelona, Spain discusses research on spina bifida-meningocele, specifically focusing on optic nerve sheath meningocele. Optic nerve sheath meningocele is an enlargement of the sheath itself, caused by a collection of cerebrospinal fluid. The report presents three cases of bilateral primary idiopathic optic nerve sheath meningocele, two of which resulted in gradual vision loss. The diagnosis was made using orbital and cranial magnetic resonance imaging with contrast and fat suppression. The research concludes that this imaging technique is crucial for diagnosis. [Extracted from the article]

A recent report from the University of Texas Austin examines the surgical treatments for Idiopathic Intracranial Hypertension (IIH) in the United States, with a focus on the emerging technique of endovascular venous stenting (EVS). The study found that the use of EVS for IIH increased significantly from 2010 to 2018, while the frequency of shunting procedures declined. EVS was associated with shorter hospital stays and lower readmission rates compared to other procedures. The research suggests a growing role for endovascular therapies in the treatment of IIH. [Extracted from the article]

New research on pseudotumor cerebri, a condition characterized by increased pressure in the brain, focuses on the role of venous sinus stenosis in contributing to the disease. Researchers at New York Presbyterian Hospital conducted a comprehensive analysis of studies on the use of stenting to treat this condition. The analysis found that venous sinus stenting can be an effective option for patients who are unresponsive to other treatments, particularly when vision is at risk. However, further research is needed to compare stenting with other interventions. [Extracted from the article]

A patent application has been filed for a method of reducing elevated intracranial pressure (ICP) in patients with idiopathic intracranial hypertension (IIH). The application proposes the use of incretins, such as GLP-1 or its analogues, to potentially reduce ICP by acting on GLP-1 receptors in the choroid plexus. The application also mentions the use of DPP-IV inhibitors to enhance the effectiveness of incretins. The inventors claim that these agents can be used alone or in combination with other pharmaceutical agents to reduce elevated ICP. [Extracted from the article]

A recent study conducted by researchers at the University of Southern California Keck School of Medicine focused on papilledema, a condition characterized by swelling of the optic nerve due to increased intracranial pressure. The study presented a unique case of a 5-year-old male with subacute vision loss and bilateral papilledema caused by a cerebellar transtentorial lesion resulting in venous sinus stenosis. The patient underwent surgery to remove the lesion, which led to a decrease in lesion size, improved sinus patency, and resolution of papilledema. The researchers concluded that patients with venous sinus lesions and symptoms of intracranial hypertension should undergo further evaluation to determine the appropriate treatment. [Extracted from the article]

A recent report from Pomona, United States discusses the topic of sensorineural hearing loss. The report focuses on a case study of a 32-year-old female who initially presented with chronic headaches and was later diagnosed with polycystic ovary syndrome (PCOS) and pseudotumor cerebri (PTC). Despite medical treatment, the patient experienced complete bilateral vision loss and later developed symptoms of tinnitus, hearing loss, and joint pain. The report explores the pathophysiological relationships between PTC and concurrent comorbidities, including PCOS, sensorineural hearing loss, empty sella (ES) syndrome, and elevated inflammatory markers. The case underscores the importance of early diagnosis and intervention for patients with PCOS experiencing chronic headaches. [Extracted from the article]

Keywords: Cardiovascular Diseases and Conditions; Cerebrovascular Diseases and Conditions; Embolism and Thrombosis; Health and Medicine; Hematology; Stroke; Surgery; Thrombosis; Vascular Diseases and Conditions; Venous Thrombosis EN Cardiovascular Diseases and Conditions Cerebrovascular Diseases and Conditions Embolism and Thrombosis Health and Medicine Hematology Stroke Surgery Thrombosis Vascular Diseases and Conditions Venous Thrombosis 671 671 1 10/30/23 20231031 NES 231031 2023 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- New research on venous thrombosis is the subject of a new report. Cardiovascular Diseases and Conditions, Cerebrovascular Diseases and Conditions, Embolism and Thrombosis, Health and Medicine, Hematology, Stroke, Surgery, Thrombosis, Vascular Diseases and Conditions, Venous Thrombosis. [Extracted from the article]

Brain Diseases and Conditions, Cardiovascular Diseases and Conditions, Central Nervous System Diseases and Conditions, Edema, Gender Health, Gender and Health, Health and Medicine, Hypertension, Intracranial Hypertension, Pseudotumor Cerebri, Therapy, Women's Health Keywords: Brain Diseases and Conditions; Cardiovascular Diseases and Conditions; Central Nervous System Diseases and Conditions; Edema; Gender Health; Gender and Health; Health and Medicine; Hypertension; Intracranial Hypertension; Pseudotumor Cerebri; Therapy; Women's Health EN Brain Diseases and Conditions Cardiovascular Diseases and Conditions Central Nervous System Diseases and Conditions Edema Gender Health Gender and Health Health and Medicine Hypertension Intracranial Hypertension Pseudotumor Cerebri Therapy Women's Health 454 454 1 09/25/23 20230925 NES 230925 2023 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on pseudotumor cerebri. Patients undergoing testosterone therapy for gender transition should be informed of the possibility of developing IIH while on treatment, with obesity possibly increasing this risk. [Extracted from the article]

"One condition associated with elevated ICP is IIH, also known as benign intracranial hypertension or pseudotumour cerebri, which is a condition of unknown aetiology characterised by elevated ICP and papilloedema. Keywords: Anhydrase; Bariatrics; Blindness; Brain Diseases and Conditions; Business; Cardiovascular Diseases and Conditions; Central Nervous System; Central Nervous System Diseases and Conditions; Cerebral Ventricles; Choroid Plexus; Drugs and Therapies; Enzymes and Coenzymes; Epithelial Cells; Eye Diseases and Conditions; Health and Medicine; Hormones; Hydrocephalus; Hypertension; Incretin Therapy; Incretins; Intracranial Hypertension; Invex Therapeutics Ltd.; Nervous System Diseases and Conditions; Neurologic Manifestations; Nutritional and Metabolic Diseases and Conditions; Obesity; Pharmaceuticals; Pseudotumor Cerebri; Risk and Prevention; Sensation Disorders; Therapeutics; Therapy; Vision Disorders EN Anhydrase Bariatrics Blindness Brain Diseases and Conditions Business Cardiovascular Diseases and Conditions Central Nervous System Central Nervous System Diseases and Conditions Cerebral Ventricles Choroid Plexus Drugs and Therapies Enzymes and Coenzymes Epithelial Cells Eye Diseases and Conditions Health and Medicine Hormones Hydrocephalus Hypertension Incretin Therapy Incretins Intracranial Hypertension Invex Therapeutics Ltd. Nervous System Diseases and Conditions Neurologic Manifestations Nutritional and Metabolic Diseases and Conditions Obesity Pharmaceuticals Pseudotumor Cerebri Risk and Prevention Sensation Disorders Therapeutics Therapy Vision Disorders 1281 1281 1 09/19/23 20230922 NES 230922 2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- A patent by the inventor Sinclair, Alex (Birmingham, GB), filed on October 8, 2020, was published online on August 29, 2023, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. [Extracted from the article]

Philadelphia, State:Pennsylvania, United States, North and Central America, Chronic Inflammatory Demyelinating Polyneuropathy, Cranial Nerve Diseases and Conditions, Demyelinating Polyneuropathy, Eye Diseases and Conditions, Health and Medicine, Nervous System Diseases and Conditions, Neurology, Neuromuscular Diseases and Conditions, Neuropathy, Optic Nerve Diseases and Conditions, Papilledema, Peripheral Nervous System Diseases and Conditions, Polyneuropathies Keywords: Philadelphia; State:Pennsylvania; United States; North and Central America; Chronic Inflammatory Demyelinating Polyneuropathy; Cranial Nerve Diseases and Conditions; Demyelinating Polyneuropathy; Eye Diseases and Conditions; Health and Medicine; Nervous System Diseases and Conditions; Neurology; Neuromuscular Diseases and Conditions; Neuropathy; Optic Nerve Diseases and Conditions; Papilledema; Peripheral Nervous System Diseases and Conditions; Polyneuropathies EN Philadelphia State:Pennsylvania United States North and Central America Chronic Inflammatory Demyelinating Polyneuropathy Cranial Nerve Diseases and Conditions Demyelinating Polyneuropathy Eye Diseases and Conditions Health and Medicine Nervous System Diseases and Conditions Neurology Neuromuscular Diseases and Conditions Neuropathy Optic Nerve Diseases and Conditions Papilledema Peripheral Nervous System Diseases and Conditions Polyneuropathies 561 561 1 04/17/23 20230421 NES 230421 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Data detailed on Nervous System Diseases and Conditions - Chronic Inflammatory Demyelinating Polyneuropathy have been presented. [Extracted from the article]

Research studies are the lifeblood of medical practice. They answer important questions and guide a practitioner through the delivery of care. Optometrists need to keep dozens of significant studies in [...]

Idiopathic intracranial hypertension (IIH) is a systemic condition characterized by increased intracranial pressure without a known cause. (1) It is a diagnosis of exclusion, meaning that life-threatening conditions must be [...]

2024 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors BELKIN, [...]

2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Central Nervous System Diseases and Conditions - Pseudotumor Cerebri [...]

2023 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on sensorineural hearing loss. According to news reporting from Pomona, [...]

2023 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on pseudotumor cerebri. According to news originating from Miami, Florida, [...]

When a patient presents with what appears to be a medical emergency, you need to act fast to prevent the situation from escalating even further and potentially resulting in irreversible, [...]

A 27-year-old Caucasian female presented to our emergency department with acute painless loss of vision in her left eye for 12 days. Five days prior to vision loss, she developed [...]

Byline: Seema. Meena, Kavita. Bhatnagar, Priyanka. Rathore, Sarbesh. Tiwari, Nikhil. Agrawal, Kirti. Jaisingh A 13-year-old girl presented to an ophthalmology department with a chief complaint of vision loss in the [...]

2022 DEC 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Eye Diseases and Conditions - Papilledema is the subject [...]

Byline: Mayur. Moreker, Darshan. Pandya, Rakesh. Singh, Vibhor. Pardasani, Sonali. Shah A 35-year-old lady presented with headache and diminution of vision in both eyes for 30-35 days. She was being [...]

2022 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Central Nervous System Diseases and Conditions - Pseudotumor [...]

Byline: Swetha. Komma, Selvakumar. Ambika, Veena. Noronha, Deepak. Arjundas We describe a 25-year-old male presenting with chronic papilledema due to cerebral venous sinus thrombosis (CVST) and was found to have [...]